ChemicalBook > Product Catalog >Organic Chemistry >Carboxylic acids and derivatives >Cyclic carboxylic acids >1H-Pyrazolo[3,4-b]pyridine-5-carboxylic acid

1H-Pyrazolo[3,4-b]pyridine-5-carboxylic acid

1H-Pyrazolo[3,4-b]pyridine-5-carboxylic acid Suppliers list
Company Name: Shangchem Co., Ltd.  
Tel: +86-21-68182121
Email:
Company Name: Shanghai Cuisen Pharmaceutical Technology Co., Ltd.  
Tel: 13472757003
Email: yongnan.wang@cendrix.cn
Company Name: SpringPharma Tech Co.,Ltd  
Tel: +86-25-68710855, +86-25-68710897
Email: sales@springpharma.net
Company Name: Shanghai Sunway Pharmaceutical Technology Co., Ltd  
Tel: 13761987713
Email: hxzheng@sunwaypharm.cn
Company Name: Wuhan ariel chemical Co., LTD.  
Tel: 18986259541 18986259541
Email: sales@3stc.com

1H-Pyrazolo[3,4-b]pyridine-5-carboxylic acid manufacturers

1H-Pyrazolo[3,4-b]pyridine-5-carboxylic acid Basic information
Product Name:1H-Pyrazolo[3,4-b]pyridine-5-carboxylic acid
Synonyms:4-b]pyridine-5-carboxylic acid;1H-Pyrazolo[3,4-b]pyridine-5-carboxylicaci;1H-Pyrazolo[3,4-b]pyridine-5-carboxylic acid
CAS:952182-02-4
MF:C7H5N3O2
MW:163.13
EINECS:
Product Categories:
Mol File:952182-02-4.mol
1H-Pyrazolo[3,4-b]pyridine-5-carboxylic acid Structure
1H-Pyrazolo[3,4-b]pyridine-5-carboxylic acid Chemical Properties
Boiling point 475.1±25.0 °C(Predicted)
density 1.617±0.06 g/cm3(Predicted)
storage temp. Sealed in dry,Room Temperature
pka10.24±0.40(Predicted)
AppearanceLight brown to off-white Solid
InChIKeyDRCBQOFOFJGWGA-UHFFFAOYSA-N
Safety Information
Hazard Codes Xi
Risk Statements 36
Safety Statements 26
HS Code 2933399990
MSDS Information
1H-Pyrazolo[3,4-b]pyridine-5-carboxylic acid Usage And Synthesis
Uses1H-Pyrazolo[3,4-B]pyridine-5-carboxylic acid is an important pharmaceutical intermediate used in the synthesis of various drug compounds.
Synthesis
1H-Pyrazolo[3,4-b]pyridine-5-carboxylic acid, 1-[(4-methoxyphenyl)methyl]-, ethyl ester

1086423-59-7

1H-PYRAZOLO[3,4-B]PYRIDINE-5-CARBOXYLIC ACID

952182-02-4

Step 5. Ethyl 1-(4-methoxybenzyl)-1H-pyrazolo[3,4-b]pyridine-5-carboxylate (4.4 g, 14 mmol) was dissolved in trifluoroacetic acid (TFA, 158 mL) and heated to 80 °C. The reaction mixture was stirred continuously at 80 °C for 4 hours. After completion of the reaction, the mixture was concentrated to dryness under reduced pressure. The residue was carefully poured into ice water and the pH was subsequently adjusted dropwise with 2 M aqueous sodium hydroxide (NaOH) to about 14. The precipitated solid was removed by filtration and the aqueous phase was washed with ethyl acetate. After combining the aqueous phases, the pH was adjusted to neutral (about 7) by slowly adding concentrated hydrochloric acid (HCl). The precipitate precipitated was collected by vacuum filtration and dried under vacuum to afford the target product 1H-pyrazolo[3,4-B]pyridine-5-carboxylic acid as a white solid (1 g, 80% yield). The product was characterized by 1H NMR (400 MHz, DMSO-d6): δ 14.38-13.62 (br, 1H), 9.07 (d, J = 1.6 Hz, 1H), 8.81 (d, J = 1.6 Hz, 1H), 8.32 (s, 1H). Mass spectrum (ESI+): m/z 164 [M+H]+.

References[1] Patent: WO2013/127266, 2013, A1. Location in patent: Page/Page column 131; 133
[2] Patent: WO2013/127267, 2013, A1. Location in patent: Page/Page column 83; 84
[3] Patent: WO2013/127268, 2013, A1. Location in patent: Page/Page column 61; 62; 63
[4] Patent: WO2013/130935, 2013, A1. Location in patent: Paragraph 0182
[5] Patent: WO2013/130943, 2013, A1. Location in patent: Paragraph 0190
Tag:1H-Pyrazolo[3,4-b]pyridine-5-carboxylic acid(952182-02-4) Related Product Information
ETHYL 4-CHLORO-1,3-DIMETHYL-1H-PYRAZOLO[3,4-B]PYRIDINE-5-CARBOXYLATE 4-(Butylamino)-1-ethyl-6-methyl 1H-pyrazolo[3,4b]pyridine-5-ethylcarboxylate hydrochloride 4-Chloro-1,3-dimethylpyrazolo[3,4-b]pyridine-5-carboxylic acid ETAZOLATE Cartazolate ETHYL 4-(3,5-DICHLOROPHENOXY)-1,3-DIMETHYL-1H-PYRAZOLO[3,4-B]PYRIDINE-5-CARBOXYLATE ETHYL 4-CHLORO-1-METHYL-1H-PYRAZOLO[3,4-B]PYRIDINE-5-CARBOXYLATE ETHYL 4-(4-METHOXYPHENOXY)-1,3-DIMETHYL-1H-PYRAZOLO[3,4-B]PYRIDINE-5-CARBOXYLATE ETHYL 1,3-DIMETHYL-4-(4-FLUOROPHENOXY)-1H-PYRAZOLO[3,4-B]PYRIDINE-5-CARBOXYLATE 1,3-DIMETHYL-4-METHOXYPYRAZOLO[3,4-B]PYRIDINE-5-CARBOXYLIC ACID Methyl 4-methoxy-1,3-dimethyl-1H-pyrazolo[3,4-b]pyridine-5-carboxylate 4-(Isopropylthio)-1,3-dimethyl-1H-pyrazolo[3,4-b]pyridine-5-carboxylic acid O1-[(4-Chloro-1,3-dimethyl-1H-pyrazolo[3,4-b]pyridin-5-yl)carbonyl]-4-methylbenzene-1-carbohydroximamide ETHYL 4-[(2-CYANOETHYL)AMINO]-1-METHYL-1H-PYRAZOLO[3,4-B]PYRIDINE-5-CARBOXYLATE ETHYL 1-METHYL-4-(PHENETHYLAMINO)-1H-PYRAZOLO[3,4-B]PYRIDINE-5-CARBOXYLATE O1-[(4-CHLORO-1,3-DIMETHYL-1H-PYRAZOLO[3,4-B]PYRIDIN-5-YL)CARBONYL]-4-(TRIFLUOROMETHYL)BENZENE-1-CARBOHYDROXIMAMIDE ETHYL 1-METHYL-4-([3-(TRIFLUOROMETHYL)BENZYL]AMINO)-1H-PYRAZOLO[3,4-B]PYRIDINE-5-CARBOXYLATE O1-[(4-CHLORO-1,3-DIMETHYL-1H-PYRAZOLO[3,4-B]PYRIDIN-5-YL)CARBONYL]-4-CHLOROBENZENE-1-CARBOHYDROXIMAMIDE